Interleukin-17A Is Associated with Alveolar Inflammation and Poor Outcomes in Acute Respiratory Distress Syndrome

Critical Care Medicine

Volumn 44, Issue 3, 2016, Pages 496-502

  Mikacenic, Carmen ^a   Hansen, Elizabeth E ^a   Radella, Frank ^a   Gharib, Sina A ^a   Stapleton, Renee D ^b   Wurfel, Mark M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Acute lung injury; cytokine; organ dysfunction; sepsis

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 8; CYTOKINE; IL17A PROTEIN, HUMAN;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ADVERSE OUTCOME; ARTICLE; BRONCHOALVEOLAR LAVAGE FLUID; CRITICALLY ILL PATIENT; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; PERMEABILITY; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ACUTE LUNG INJURY; AGED; BLOOD; CHEMISTRY; IMMUNOLOGY; INFLAMMATION; INTENSIVE CARE UNIT; LEUKOCYTE COUNT; LUNG ALVEOLUS; METABOLISM; MIDDLE AGED; NEUTROPHIL; ORGAN DYSFUNCTION SCORE; PATHOPHYSIOLOGY; SEPSIS; TREATMENT OUTCOME;

ACUTE LUNG INJURY; AGED; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; FEMALE; HUMANS; INFLAMMATION; INTENSIVE CARE UNITS; INTERLEUKIN-17; INTERLEUKIN-8; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NEUTROPHILS; ORGAN DYSFUNCTION SCORES; PULMONARY ALVEOLI; RESPIRATORY DISTRESS SYNDROME, ADULT; SEPSIS; TREATMENT OUTCOME;

EID: 84959230474     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000001409     Document Type: Article

References (41)

1. Rubenfeld GD, Caldwell E, Peabody E, et al: Incidence and outcomes of acute lung injury. N Engl J Med 2005; 353:1685-1693
2. Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med 2000; 342:1334-1349
3. Abraham E, Kaneko DJ, Shenkar R: Effects of endogenous and exogenous catecholamines on LPS-induced neutrophil trafficking and activation. Am J Physiol 1999; 276:L1-L8
4. Parsey MV, Tuder RM, Abraham E: Neutrophils are major contributors to intraparenchymal lung IL-1 beta expression after hemorrhage and endotoxemia. J Immunol 1998; 160:1007-1013
5. Iwakura Y, Nakae S, Saijo S, et al: The roles of IL-17A in inflammatory immune responses and host defense against pathogens. Immunol Rev 2008; 226:57-79
6. Happel KI, Zheng M, Young E, et al: Cutting edge: Roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J Immunol 2003; 170:4432-4436
7. Stark MA, Huo Y, Burcin TL, et al: Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 2005; 22:285-294
8. Takatori H, Kanno Y, Watford WT, et al: Lymphoid tissue inducerlike cells are an innate source of IL-17 and IL-22. J Exp Med 2009; 206:35-41
9. Ferretti S, Bonneau O, Dubois GR, et al: IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J Immunol 2003; 170:2106-2112
10. Michel ML, Keller AC, Paget C, et al: Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J Exp Med 2007; 204:995-1001
11. Ye P, Garvey PB, Zhang P, et al: Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am J Respir Cell Mol Biol 2001; 25:335-340
12. Wu Q, Martin RJ, Rino JG, et al: IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae infection. Microbes Infect 2007; 9:78-86
13. Sutherland TE, Logan N, Rückerl D, et al: Chitinase-like proteins promote IL-17-mediated neutrophilia in a tradeoff between nematode killing and host damage. Nat Immunol 2014; 15:1116-1125
14. Li C, Yang P, Sun Y, et al: IL-17 response mediates acute lung injury induced by the 2009 pandemic influenza A (H1N1) virus. Cell Res 2012; 22:528-538
15. Crowe CR, Chen K, Pociask DA, et al: Critical role of IL-17RA in immunopathology of influenza infection. J Immunol 2009; 183:5301-5310
16. Stoppelenburg AJ, Salimi V, Hennus M, et al: Local IL-17A potentiates early neutrophil recruitment to the respiratory tract during severe RSV infection. PLoS One 2013; 8:e78461
17. Agache I, Ciobanu C, Agache C, et al: Increased serum IL-17 is an independent risk factor for severe asthma. Respir Med 2010; 104:1131-1137
18. Bullens DM, Truyen E, Coteur L, et al: IL-17 mRNA in sputum of asthmatic patients: Linking T cell driven inflammation and granulocytic influx Respir Res 2006; 7:135
19. Brodlie M, McKean MC, Johnson GE, et al: Raised interleukin-17 is immunolocalised to neutrophils in cystic fibrosis lung disease. Eur Respir J 2011; 37:1378-1385
20. Tan HL, Regamey N, Brown S, et al: The Th17 pathway in cystic fibrosis lung disease. Am J Respir Crit Care Med 2011; 184:252-258
21. Zhang L, Cheng Z, Liu W, et al: Expression of interleukin (IL)-10, IL-17A and IL-22 in serum and sputum of stable chronic obstructive pulmonary disease patients. COPD 2013; 10:459-465
22. Roos AB, Sethi S, Nikota J, et al: IL-17A and the promotion of neutrophilia in acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2015; 192:428-437
23. Miller EJ, Cohen AB, Matthay MA: Increased interleukin-8 concentrations in the pulmonary edema fluid of patients with acute respiratory distress syndrome from sepsis. Crit Care Med 1996; 24:1448-1454
24. Miller EJ, Cohen AB, Nagao S, et al: Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis 1992; 146:427-432
25. Calfee CS, Eisner MD, Ware LB, et al; Acute Respiratory Distress Syndrome Network, National Heart, Lung, and Blood Institute: Trauma-associated lung injury differs clinically and biologically from acute lung injury due to other clinical disorders. Crit Care Med 2007; 35:2243-2250
26. Calfee CS, Janz DR, Bernard GR, et al; the NIH NHLBI ARDS Network: Distinct molecular phenotypes of direct versus indirect ARDS in single and multi-center studies. Chest 2015; 147:1539-1548
27. Shaver CM, Bastarache JA: Clinical and biological heterogeneity in acute respiratory distress syndrome: Direct versus indirect lung injury. Clin Chest Med 2014; 35:639-653
28. Bernard GR, Artigas A, Brigham KL, et al: The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149:818-824
29. Stapleton RD, Martin TR, Weiss NS, et al: A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injury. Crit Care Med 2011; 39:1655-1662
30. Ranieri VM, Rubenfeld GD, Thompson BT, et al: Acute respiratory distress syndrome: The Berlin Definition. JAMA 2012;307:2526-2533
31. Vincent JL, Moreno R, Takala J, et al: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22:707-710
32. Wurfel MM, Gordon AC, Holden TD, et al: Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis. Am J Respir Crit Care Med 2008; 178:710-720
33. Knaus WA, Draper EA, Wagner DP, et al: APACHE II: A severity of disease classification system. Crit Care Med 1985; 13:818-829
34. Matthay MA, Zemans RL: The acute respiratory distress syndrome: Pathogenesis and treatment. Annu Rev Pathol 2011; 6:147-163
35. Williams AE, Chambers RC: The mercurial nature of neutrophils: Still an enigma in ARDS Am J Physiol Lung Cell Mol Physiol 2014; 306:L217-L230
36. Miyamoto M, Prause O, Sjöstrand M, et al: Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. J Immunol 2003; 170:4665-4672
37. Tiringer K, Treis A, Fucik P, et al: A Th17-and Th2-skewed cytokine profile in cystic fibrosis lungs represents a potential risk factor for Pseudomonas aeruginosa infection. Am J Respir Crit Care Med 2013; 187:621-629
38. Kawaguchi M, Kokubu F, Kuga H, et al: Modulation of bronchial epithelial cells by IL-17. J Allergy Clin Immunol 2001; 108:804-809
39. Yu ZX, Ji MS, Yan J, et al: The ratio of Th17/Treg cells as a risk indicator in early acute respiratory distress syndrome. Crit Care 2015; 19:82
40. Hagau N, Slavcovici A, Gonganau DN, et al: Clinical aspects and cytokine response in severe H1N1 influenza A virus infection. Crit Care 2010; 14:R203
41. Bellini A, Marini MA, Bianchetti L, et al: Interleukin (IL)-4, IL-13, and IL-17A differentially affect the profibrotic and proinflammatory functions of fibrocytes from asthmatic patients. Mucosal Immunol 2012; 5:140-149